Back to Search Start Over

Measuring Clinical Treatment Response in Myasthenia Gravis

Authors :
Laura Herbelin
Mazen M. Dimachkie
Carolina Barnett
Richard J. Barohn
Source :
Neurologic Clinics. 36:339-353
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Abstract

In this article we provide an overview of health-related outcome measurement-to better understand what different outcomes used in myasthenia actually measure-and to provide some guidance when choosing measures based on the clinical context and question. In myasthenia, the most commonly used outcome measures are aimed at assessing the signs and symptoms. In this review, we provide a summary of the most commonly used outcome measures. We discuss instruments that gauge disease overall health impact, such as on disability and quality of life. Finally, we discuss other relevant outcomes such as steroid-sparing effects and the role of surrogate markers.

Details

ISSN :
07338619
Volume :
36
Database :
OpenAIRE
Journal :
Neurologic Clinics
Accession number :
edsair.doi.dedup.....d2ac47552dbd30bb602a10a02cf00862